- Capital Cube•3 days ago
Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to Ocera Therapeutics, Inc. Here are 5 ETF’s with the largest exposure to OCRX-US. Comparing the performance and risk of Ocera Therapeutics, Inc. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)
- GlobeNewswire•10 days agoOcera Announces Enrollment Completion From Phase 2a NIH-Sponsored Study of OCR-002 in the Treatment of Patients with Acute Liver Failure
PALO ALTO, Calif. and RESEARCH TRIANGLE PARK, N.C., Sept. 21, 2016-- Ocera Therapeutics, Inc., today announced completion of enrollment in STOP-ALF, a Phase 2 a clinical trial to evaluate the S afety and ...
- GlobeNewswire•11 days ago
PALO ALTO, Calif. and RESEARCH TRIANGLE PARK, N.C., Sept. 20, 2016-- Ocera Therapeutics, Inc., a clinical stage biopharmaceutical company focused on acute and chronic orphan liver diseases, today announced ...
Ocera Therapeutics, Inc. (OCRX)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
|Bid||2.21 x 2500|
|Day's Range||2.60 - 2.65|
|52wk Range||1.76 - 4.57|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-1.95|
|Avg Vol (3m)||163,870|
|Dividend & Yield||N/A (N/A)|